acquisition of resistance to the given anti-GBM therapies. The neural stem cell marker CD133, known as prominin-1, has been widely used as a CSCs marker in GBM. Although ... there is some controversy regarding…
Objective: Influence of CD133 + expression on patients? survival and resistance of CD133 + cells to anti-tumor agents were studied in gastric cancer (GC). Methods & Results: As revealed by Western blot ... lower CD133 +…
cells that may explain tumor initiation and resistance to given anti-GBM therapies. The CD133 neural stem cell marker, known as prominin-1, has been widely used ... marker in GBM. Although there is some controversy…
therapy. Methods: In this study, we evaluated the immunohistochemical expression of OCT-4 and CD133 in 30 cases of rectosigmoid adenocarcinoma which received neoadjuvant chemoradiotherapy in relation to other…
Cancer stem cells (CSCs) that display tumour-initiating properties have recently been identified. CD133, a surface glycoprotein linked to organspecific stem cells, has been described as a marker of CSCs ... aggressive…
CD133 is a type of a biomarker of rectal cancer stem cells. Recent research suggested that colorectal cancer stem cells have the radiotherapy and chemotherapy resistance. This study intends ... explore CD133 expression…
average survival time of these patients are gathered and compared with following groups: CD133+, CD133-, MYCN ≥ 5, MYCN<5, CD133+ plus MYCN ≥ 5, CD133- plus MYCN<5. Results: CD133+ CSCs ... differentiate into neuron…
CD133 is well documented to be expressed by tumor initiating cells and epithelial progenitor cells which were proposed to have predominant roles for tumor recurrence and pre-metastatic niche formation ... respectively…
predictive factors are highly relevant. The purpose is to evaluate the prognostic significance of CD133 expression and to investigate the utility as biomarker of prognosis of metastatic colorectal cancer (mCRC…
various malignant neoplasms is not well addressed. In the current study, we compared CD133, a membranous stem cell marker, in several types of adenocarcinoma originating in colon, breast and kidney ... from colon, 40…
tumour relapse. Colorectal cancer stem cells express cellspecific surface markers, including amongst others, CD133, EpCAM, CD44, CD166, and CD94f. In the present study, we aimed to characterisecellpopulations in the…
Objective: CD133 is a pentaspan membrane protein expressed by the so-called cancer stem cells (CSC) in the majority of human cancers. The aim of this study was to analyze ... CD133 expression levels in specimens of oral…
have all been linked to Cancer Stem Cells (CSCs). A well-known CSC marker, CD133, is essential to the biology of gliomas and may be a prognostic predictor. Objective ... assess the immunohistochemistry expression levels…
Stem cells”. These cells express a membranous protein known as “Prominin-1” or “CD133”. CD133 exhibits 7 isoforms, distributed in different tissues of the body. The isolation and understanding ... syndrome, cerebral…
Objective: To evaluate role of stem cell markers Aldh1a1, Cd133 and Oct 4 and its association with Epithelial Mesenchymal Transition (EMT) markers in breast cancer patients. Materials and method: Total…
been identified to be capable of suppressing glioma cell growth through targeting CREB1 or CD133. However, whether miR-200b affects the biological behavior (proliferation, invasion, and migration) of glioma cells…
focus on the relation of EMT with the expression of TICs marker CD133. Methods: KATO-III cells were cultured with TGF-ß1, the morphological change was observed under phase-contrast ... detect the expression of Snail…
stem cells (CSCs). Recent studies indicate the involvement of stem cell markers (CD44, α2β1, CD133, NANOG, SOX2 and OCT4) in the maintenance of CSCs and relapse of the disease ... positive (AR+) LNCaP cells. Only a sub…
simultaneous investigation into renal stem cells, which are similar to stem cell populations (CD133+) in normal part of the human kidney of a patient afflicted with renal cell carcinoma. Methods ... cell groups (A and…
different role in tumer cell death and survival, the effection of autophagy in CD133 + stem cell like caner cells is still unclear. The purpose of this study was to investigate ... change and effection of autophagy…
cells. Interestingly, TPGS- FA/NC (10, 20, 40 μg/mL) drastically reduced the EpCAM+/CD133+ cell numbers, which suppressed the sphere formation and inhibited the expression of stem cell marker ... Huh7 spheroids…
rectal cancer. Several markers for CSCs have been proposed in CRC, OCT-4 and CD133 have been the most frequently researched. This study was targeted to evaluate the immunohistochemical expression ... stem cell markers…
cell line, 2) on the epigenetic regulation. Methods: A549 cell line was sorted for CD133 surface expression and side population (SP) profile by flow cytometry. A549 cells fraction obtained were ... fractions of A549…
properties and malignant potential exists in solid tumors. Recent evidences indicate that transmembrane protein CD133 and adhesion molecule CD44 , can be used as markers of CSCs. Methods: Immunohistochemistry was…
also been shown that an elevated expression of the stem cell marker CD133 was associated with Line-1 demethylation in hepatocellular carcinoma. That relationship of Line-1 demethylation ... CD133 expression of cancer…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.